Sanovel Named Grand Finalist at Peryön İnsana Değer Awards

Sanovel, a leader in the pharmaceutical sector with strong production technology, quality focus, R&D capabilities and specialized human resources, has been recognized as a finalist in the Leadership in Human Value – Grand Prize category at the Human Value Awards organized by the Turkish Human Resources Association (PERYON).

Sanovel, one of the leading companies in the Turkish pharmaceutical sector, has received the finalist award in the Leadership in Human Value – Grand Prize category at the Human Value Awards organized by the Turkish Human Resources Association (PERYON) to recognize innovative, creative and successful practices in human resources. Sanovel, which took the stage at the Human Value Awards, now in its 16th year, was recognized for this prestigious award through its work on increasing employee engagement and talent management.

Creating Value for Our Employees is Our Priority

Derya Oral, Director of Human Resources and Corporate Communications at Sanovel, who received the award from Assoc. Prof. Dr. Salim Atay, Head of the Presidency Human Resources Office of the Turkish Republic, and Ebru Taşcı Firuzbay, Chair of PERYON Board of Management, stated: "At Sanovel, people are at the center of our work, all our policies and practices. Through pioneering and innovative practices in the human resources field that make a difference in the sector, Sanovel, within the framework of a 'balanced and valuable life' human resources approach, carries out work that adds value to employees in their career journeys. Through our projects aimed at uncovering the potential of our employees at Sanovel, we aim to contribute not only to our organization's future but also to the sector's future. I thank all team members who contributed to this success and PERYON for recognizing Sanovel for this award."

About Sanovel

Sanovel, one of the leading companies in the Turkish pharmaceutical sector, was founded in 1983 by Pharmacist Erol Toksöz. With its strong portfolio and product diversity in key therapeutic areas, Sanovel has a production capacity of 227 million boxes per year and holds European cGMP (Good Manufacturing Practice) certification. Sanovel is the first and only Turkish pharmaceutical company approved by the U.S. Food and Drug Administration (FDA), recognized as the world's largest health authority, without major and critical findings upon inspection. The company stands out in the sector with its strong R&D capabilities and expertise and achievements in patents and intellectual property. As a company that has brought the first generic equivalent products to the market in many therapeutic areas, Sanovel continues to work with all its strength to contribute to the Turkish pharmaceutical industry and the country's economy and to serve the lifelong health of communities with over 1,700 employees.